Linking resistin, inflammation, and cardiometabolic diseases

Hyeong Kyu Park, Mi Kyung Kwak, Hye Jeong Kim, Rexford S. Ahima

Research output: Contribution to journalReview article

Abstract

Adipose tissue secretes a variety of bioactive substances that are associated with chronic inflammation, insulin resistance, and an increased risk of type 2 diabetes mellitus. While resistin was first known as an adipocyte-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents, it is predominantly expressed and secreted by macrophages in humans. Epidemiological and genetic studies indicate that increased resistin levels are associated with the development of insulin resistance, diabetes, and cardiovascular disease. Resistin also appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and the formation of foam cells. Thus, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with cardiovascular disease and heart failure. Furthermore, recent evidence suggests that resistin is associated with atherogenic dyslipidemia and hypertension. The present review will focus on the role of human resistin in the pathogeneses of inflammation and obesity-related diseases.

LanguageEnglish (US)
Pages239-247
Number of pages9
JournalKorean Journal of Internal Medicine
Volume32
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Resistin
Inflammation
Insulin Resistance
Atherosclerosis
Cardiovascular Diseases
Obesity
Arteritis
Foam Cells
Adipokines
Dyslipidemias
Vascular Smooth Muscle
Adipocytes
Type 2 Diabetes Mellitus
Smooth Muscle Myocytes
Adipose Tissue
Epidemiologic Studies
Rodentia
Heart Failure
Macrophages
Cell Proliferation

Keywords

  • Cardiovascular diseases
  • Diabetes mellitus
  • Inf lammation
  • Obesity
  • Resistin
  • Type 2

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Linking resistin, inflammation, and cardiometabolic diseases. / Park, Hyeong Kyu; Kwak, Mi Kyung; Kim, Hye Jeong; Ahima, Rexford S.

In: Korean Journal of Internal Medicine, Vol. 32, No. 2, 2017, p. 239-247.

Research output: Contribution to journalReview article

Park, Hyeong Kyu ; Kwak, Mi Kyung ; Kim, Hye Jeong ; Ahima, Rexford S./ Linking resistin, inflammation, and cardiometabolic diseases. In: Korean Journal of Internal Medicine. 2017 ; Vol. 32, No. 2. pp. 239-247
@article{df440e15ea7a496db6a62fcaaabd12d3,
title = "Linking resistin, inflammation, and cardiometabolic diseases",
abstract = "Adipose tissue secretes a variety of bioactive substances that are associated with chronic inflammation, insulin resistance, and an increased risk of type 2 diabetes mellitus. While resistin was first known as an adipocyte-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents, it is predominantly expressed and secreted by macrophages in humans. Epidemiological and genetic studies indicate that increased resistin levels are associated with the development of insulin resistance, diabetes, and cardiovascular disease. Resistin also appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and the formation of foam cells. Thus, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with cardiovascular disease and heart failure. Furthermore, recent evidence suggests that resistin is associated with atherogenic dyslipidemia and hypertension. The present review will focus on the role of human resistin in the pathogeneses of inflammation and obesity-related diseases.",
keywords = "Cardiovascular diseases, Diabetes mellitus, Inf lammation, Obesity, Resistin, Type 2",
author = "Park, {Hyeong Kyu} and Kwak, {Mi Kyung} and Kim, {Hye Jeong} and Ahima, {Rexford S.}",
year = "2017",
doi = "10.3904/kjim.2016.229",
language = "English (US)",
volume = "32",
pages = "239--247",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "2",

}

TY - JOUR

T1 - Linking resistin, inflammation, and cardiometabolic diseases

AU - Park,Hyeong Kyu

AU - Kwak,Mi Kyung

AU - Kim,Hye Jeong

AU - Ahima,Rexford S.

PY - 2017

Y1 - 2017

N2 - Adipose tissue secretes a variety of bioactive substances that are associated with chronic inflammation, insulin resistance, and an increased risk of type 2 diabetes mellitus. While resistin was first known as an adipocyte-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents, it is predominantly expressed and secreted by macrophages in humans. Epidemiological and genetic studies indicate that increased resistin levels are associated with the development of insulin resistance, diabetes, and cardiovascular disease. Resistin also appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and the formation of foam cells. Thus, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with cardiovascular disease and heart failure. Furthermore, recent evidence suggests that resistin is associated with atherogenic dyslipidemia and hypertension. The present review will focus on the role of human resistin in the pathogeneses of inflammation and obesity-related diseases.

AB - Adipose tissue secretes a variety of bioactive substances that are associated with chronic inflammation, insulin resistance, and an increased risk of type 2 diabetes mellitus. While resistin was first known as an adipocyte-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents, it is predominantly expressed and secreted by macrophages in humans. Epidemiological and genetic studies indicate that increased resistin levels are associated with the development of insulin resistance, diabetes, and cardiovascular disease. Resistin also appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and the formation of foam cells. Thus, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with cardiovascular disease and heart failure. Furthermore, recent evidence suggests that resistin is associated with atherogenic dyslipidemia and hypertension. The present review will focus on the role of human resistin in the pathogeneses of inflammation and obesity-related diseases.

KW - Cardiovascular diseases

KW - Diabetes mellitus

KW - Inf lammation

KW - Obesity

KW - Resistin

KW - Type 2

UR - http://www.scopus.com/inward/record.url?scp=85014852303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014852303&partnerID=8YFLogxK

U2 - 10.3904/kjim.2016.229

DO - 10.3904/kjim.2016.229

M3 - Review article

VL - 32

SP - 239

EP - 247

JO - Korean Journal of Internal Medicine

T2 - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 2

ER -